Shaker Investments’s Supernus Pharmaceuticals SUPN Stock Holding History

Shaker Investments’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-29,005	Closed	-$960K	–	88
2019 Q2	$960K	Sell	29,005 -33,835	-54%	-$1.16M	0.64%	43
2019 Q1	$2.2M	Sell	62,840 -132	-0.2%	-$4.91K	1.52%	23
2018 Q4	$2.09M	Buy	62,972 +13,355	+27%	+$574K	1.82%	16
2018 Q3	$2.5M	Sell	49,617 -25	-0.1%	-$1.24K	1.54%	16
2018 Q2	$2.97M	Buy	49,642 +7,002	+16%	+$363K	1.83%	15
2018 Q1	$1.95M	Buy	+42,640	New	+$1.78M	1.21%	26

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

ACM

Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return

Shaker Investments's SUPN Position: Q3 2019 in Review

Shaker Investments sold out of Supernus Pharmaceuticals (SUPN) in Q3 2019, closing a stake of 29,005 shares — an estimated $960K sold.

Shaker Investments first reported a position in SUPN in Q1 2018 and held it in 6 quarters. The position peaked at $2.97M in Q2 2018. 243 funds tracked by Wall St. Rank hold SUPN as of Q3 2019.

Shaker Investments reported no remaining Supernus Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Shaker Investments sold 29,005 Supernus Pharmaceuticals shares in Q3 2019, an estimated $960K.
Shaker Investments first reported a position in Supernus Pharmaceuticals in Q1 2018 and held it in 6 quarters.
Shaker Investments's Supernus Pharmaceuticals position peaked at $2.97M in Q2 2018.
243 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2019.

Based on Shaker Investments's 13F filing for Q3 2019, filed 28 Oct 2019.